Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
4.030
-0.080 (-1.95%)
At close: Apr 28, 2026, 4:00 PM EDT
4.020
-0.010 (-0.25%)
Pre-market: Apr 29, 2026, 7:43 AM EDT
Oramed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 163 | 113 | 98 | 93 | 471 | 544 | |
| Market Cap Growth | 89.09% | 16.28% | 4.69% | -80.20% | -13.48% | -15.00% | |
| Enterprise Value | 30 | -21 | -46 | -9 | 311 | 444 | |
| Last Close Price | 4.03 | 2.66 | 2.26 | 2.15 | 11.21 | 13.31 | |
| PE Ratio | 2.69 | 1.79 | - | 16.87 | - | - | |
| PS Ratio | 81.50 | 56.72 | - | 69.54 | 174.08 | 200.54 | |
| PB Ratio | 0.79 | 0.57 | 0.67 | 0.57 | 3.11 | 3.26 | |
| P/TBV Ratio | 0.82 | 0.57 | 0.67 | 0.57 | 3.10 | 3.27 | |
| EV/Sales Ratio | 14.78 | - | - | - | 115.15 | 163.83 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.32 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -0.67 | -0.67 | -0.97 | -0.69 | -1.02 | -0.90 | |
| Net Debt / EBITDA Ratio | 8.92 | 8.92 | 11.25 | 7.21 | 3.82 | 4.05 | |
| Net Debt / FCF Ratio | 14.58 | 14.58 | 16.79 | 10.64 | 5.45 | 4.48 | |
| Asset Turnover | 0.01 | 0.01 | - | 0.01 | 0.02 | - | |
| Quick Ratio | 6.62 | 6.62 | 24.97 | 3.05 | 27.10 | 19.85 | |
| Current Ratio | 6.98 | 6.98 | 25.19 | 3.06 | 27.34 | 20.08 | |
| Return on Equity (ROE) | 37.10% | 37.10% | -12.39% | 3.24% | -23.77% | - | |
| Return on Assets (ROA) | -4.88% | -4.88% | -4.25% | -5.16% | -14.95% | - | |
| Return on Invested Capital (ROIC) | -17.91% | -32.68% | -45.44% | -64.63% | -473.17% | -169.08% | |
| Return on Capital Employed (ROCE) | -7.10% | -7.10% | -8.50% | -9.40% | -26.00% | -21.70% | |
| Earnings Yield | 38.80% | 56.46% | -19.54% | 5.93% | -7.77% | -6.44% | |
| FCF Yield | -5.62% | -8.07% | -8.64% | -11.32% | -6.04% | -6.14% | |
| Buyback Yield / Dilution | -3.84% | -3.84% | -0.70% | -4.02% | -5.08% | -30.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.